Products

知行笔记

Composable open-source blog for recording, sharing, and owning posts.

zxctb.top SourceCreator Economy & Community / Newsletter & Blogging Platforms

AI Benchmark
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Launched
2y ago
2024-11-14 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on 中国独立开发者Launch

    知行笔记 - Note, Share, Possess — 开源内容管理系统,可组合开源博客 知行博客 搭建个人博客,记录,分享,拥有!

    Nov 14, 2024 · 2y agoLaunch page

Open Source & Self-Hosting

GitHub · MCP / Skill
GitHub Stars
Public repo
Forks
—
License
See repository
Primary language
—

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2019-01-11

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-08-01

Key pages

Weekly snapshots

No page snapshots yet. Once followed, home and pricing pages are captured weekly.

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does 知行笔记 get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is 知行笔记 and what platforms does it support?
知行笔记 is catalogued under Newsletter & Blogging Platforms: Composable open-source blog for recording, sharing, and owning posts. Supported platforms: Web.
Is 知行笔记 open source?
知行笔记 has a public repository (https://github.com/xtthaop/zxnote-web) with its source repository published.Source

Related products in this category

Creator Economy & Community / Newsletter & Blogging Platforms

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.